Stockreport

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2024

Fulcrum Therapeutics, Inc.  (FULC) 
Last fulcrum therapeutics, inc. earnings: 3/5 07:00 am Check Earnings Report
PDF ? Patient enrollment and site activation progressing in Phase 1b PIONEER trial of pociredir in sickle cell disease (SCD) ? ? Ended the third quarter of 2024 with $257.2 [Read more]